Comparative Study of Adalimumab, Infliximab and Certolizumab Pegol in the Treatment of Cystoid Macular Edema Due to Behçet’s Disease †

Nuria Barroso-García, José Luis Martín-Varillas, Iván Ferraz-Amaro, Lara Sánchez-Bilbao, Adrián Martín-Gutiérrez, Alfredo Adán, Inés Hernanz-Rodríguez, Emma Beltrán-Catalán, Miguel Cordero-Coma, David Díaz-Valle, Marisa Hernández-Garfella, Lucía Martínez-Costa, Manuel Díaz-Llopis, José M Herreras, O · 2024

Read Comparative Study of Adalimumab, Infliximab and Certolizumab Pegol in the Treatment of Cystoid Macular Edema Due to Behçet’s Disease † by Nuria Barroso-García, José Luis Martín-Varillas, Iván Ferraz-Amaro, Lara Sánchez-Bilbao, Adrián Martín-Gutiérrez, Alfredo Adán, Inés Hernanz-Rodríguez, Emma Beltrán-Catalán, Miguel Cordero-Coma, David Díaz-Valle, Marisa Hernández-Garfella, Lucía Martínez-Costa, Manuel Díaz-Llopis, José M Herreras, O (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11642836.txt.

Description

A Spanish team compares three immune drugs for sight-threatening eye swelling in Behçet's disease, in a 2024 study. The disease can inflame the eye's center until vision blurs, and it is a top cause of blindness from eye inflammation. The patients in this study had already failed steroids and standard immune drugs. Fifty patients, covering 75 eyes, got one of three blocker drugs that share the same target.

Care teams tracked eye thickness on scans, sharpness of vision, and signs of inflammation for two years. The three groups started alike in age and background, though one group had worse scores on some eye measures at the start. Models that handle repeat visits weighed how each drug held up over time. The study gives eye doctors a head-to-head record for a choice that often rests on habit or cost alone.

Catalog record

CREATORNuria Barroso-García, José Luis Martín-Varillas, Iván Ferraz-Amaro, Lara Sánchez-Bilbao, Adrián Martín-Gutiérrez, Alfredo Adán, Inés Hernanz-Rodríguez, Emma Beltrán-Catalán, Miguel Cordero-Coma, David Díaz-Valle, Marisa Hernández-Garfella, Lucía Martínez-Costa, Manuel Díaz-Llopis, José M Herreras, O
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE27 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11642836

Browse the full library · About the Tower of Babel